BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38733195)

  • 1. [Research progress on the effect of hepatitis B virus DNA integration on antiviral therapy].
    Zhao J; Chen XY; Zheng SJ
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):375-379. PubMed ID: 38733195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy.
    Burdette DL; Lazerwith S; Yang J; Chan HLY; Delaney Iv WE; Fletcher SP; Cihlar T; Feierbach B
    PLoS One; 2022; 17(4):e0262516. PubMed ID: 35363817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
    Hu Y; Cheng X; Cao F; Huang A; Tavis JE
    Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
    Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
    Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
    Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
    Wong GLH; Gane E; Lok ASF
    J Hepatol; 2022 Jun; 76(6):1249-1262. PubMed ID: 35589248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis.
    Yu S; Jianqin H; Wei W; Jianrong H; Yida Y; Jifang S; Liang Y; Zhi C; Hongyu J
    Ann Hepatol; 2013; 12(3):364-72. PubMed ID: 23619252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent Advances in Hepatitis B Virus Antivirals].
    Liu Q; Yao C; Guo X; Hu K
    Bing Du Xue Bao; 2016 Sep; 32(5):650-8. PubMed ID: 30004193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
    Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
    Novotny LA; Evans JG; Su L; Guo H; Meissner EG
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.